🇺🇸 FDA
Patent

US 8575170

Flurbiprofen analogs and methods of use in treating cancer

granted A61KA61K31/19A61P

Quick answer

US patent 8575170 (Flurbiprofen analogs and methods of use in treating cancer) held by The Regents of the University of Colorado, a Body Corporate expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/19, A61P, A61P35/00